Screener
CorMedix CRMD Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 90.2%-5.5pp | 91.9%-3.5pp | 92.9%0.0pp | 94.4%— | 95.7%— | |
| Operating margin | 47%— | 48.4%— | 48.2%— | —— | —— | |
| Net margin | 37.6%— | 41.9%— | 48%— | —— | —— | |
| Returns | ||||||
| Return on equity | 51%— | 60.7%— | 61%— | —— | —— | |
| Efficiency | ||||||
| Asset turnover | 0.8×0.0× | 0.8×+0.1× | 0.7×+0.2× | 0.5×— | 0.8×— | |
| Liquidity | ||||||
| Current ratio | 2.6×-5.3× | 3×-1.2× | 2.1×-1.3× | 1.9×-2.0× | 7.8×+3.0× | |
| Per Share | ||||||
| Book value per share | $4.98+62.4% | $4.70+182% | $5.05+251% | $4.34+335% | $3.07+283% | |
| Valuation | ||||||
| Market capitalization | $578.35M-32.9% | $536.75M+33.7% | $916.32M+86.4% | $868.17M+92.3% | $1.07B+348% | |
| Price / earnings | 3.3×— | 3.2×— | 6.1×— | —— | —— | |
| Price / sales | 1.3×-2.8× | 1.3×-3.5× | 2.9×-8.4× | 4.1×— | 8.8×— | |
| Price / book | 1.3×-1.1× | 1.2×-2.3× | 2.3×-3.5× | 2.3×-5.4× | 4.8×-0.3× |
FAQ
- What are CorMedix's profit margins?
- CorMedix (CRMD) runs a 90.2% gross margin and a 47.0% operating margin, with a 37.6% net margin.
- Where do CorMedix's ratios come from?
- Every ratio is computed from CorMedix's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
